Intellipharmaceutics International Inc. (IPCI)

[fabius]

We need, in this order:

1 an immediate update on the Focalin bio-equivalence matter; the FDA request it's not IPCI's fault , but I think it's unacceptable not have any kind of information after more than 2months.

2 the approval of Focalin other strenghts (related to point 1)

3 the approval before year end of 1 generic

4 the announcement of a Rexista super-lucrative partnership



if this happen we could see the share price explode by jan 2016; if number 3 comes before 1-2 then we coulld see even a triple digit performance...but this would just take us where we were last year.

It's time to see our patience rewarded.

Otherwise I think that 1.50 will be touched shortly (hope to be strongly wrong !)